pleconaril and oxazoles

pleconaril has been researched along with oxazoles in 92 studies

Research

Studies (92)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (13.04)	18.2507
2000's	44 (47.83)	29.6817
2010's	30 (32.61)	24.3611
2020's	6 (6.52)	2.80

Authors

Authors	Studies
Abdel-Rahman, SM; Kearns, GL	2
Abdel-Rahman, SM; Blowey, DL; Jacobs, RF; James, LP; Kearns, GL; Marshall, JD; Wells, TG	1
Groarke, JM; Pevear, DC	1
Rotbart, HA	1
Groarke, JM; Pevear, DC; Seipel, ME; Tull, TM	1
Hayden, FG	1
Diana, GD; McKinlay, MA; Rogers, JM	1
Bossart, W; Güngör, T; Lauener, R; Schmugge, M; Seger, RA	1
Le Moing, V	1
Sawyer, MH	3
Schiff, GM; Sherwood, JR	1
Flückiger, U	1
Steele, RW; Yarush, LI	1
Crump, CE; Hayden, FG; Kaiser, L	1
Abdel-Rahman, SM; Bradley, JS; Capparelli, EV; Jacobs, RF; James, LP; Johnson, KM; Kearns, GL	1
Ballesteros, F; Reina, J	1
Forman, MS; Lederman, HM; Nowak-Wegrzyn, A; Phipatanakul, W; Winkelstein, JA	1
Turner, RB	1
Rotbart, HA; Webster, AD	1
Romero, JR	1
Nigrovic, LE	1
Ansevin, CF	1
Billich, A	1
Alonso, EM; Aradottir, E; Shulman, ST	1
Black, J; Leeman, B; Mundy, LM; Reed, N; Starlin, R; Trulock, E	1
Chang, CM; Chang, YL; Chen, SJ; Chern, JH; Hsu, MC; Lee, CC; Lee, YC; Leong, MK; Li, WT; Peng, KC; Shia, KS; Shih, SR; Tai, CL; Tseng, HY; Tseng, SN	1
Blatter, MM; Coats, T; Hassman, HA; Hayden, FG; Kim, K; Liu, S; Zhang, B	1
Senior, K	1
Ashkenazi, S; Bauer, S; Gottesman, G; Levi, I; Litmanovitz, I; Sirota, L	1
Florea, NR; Maglio, D; Nicolau, DP	1
Buscombe, JR; Johnson, MA; Thomson, AP; Tormey, VJ; Webster, AD	1
Abzug, MJ; Blount, S; Bradley, J; Capparelli, EV; Cloud, G; Kimberlin, DW; Lakeman, F; Lepow, M; Mani, C; Powell, D; Romero, J; Sánchez, PJ; Whitley, RJ	1
Andrews, PI; Bye, AM; Craig, ME; Lahra, MM; Nolan, MA; Prager, PC; Rawlinson, WD; Williams, GD	1
Coats, TL; Collett, M; Cooper, EC; Hayden, FG; Herrington, DT; Hudson, S; Kim, K; Liu, S; McKinlay, M; Pevear, DC; Villano, SA	1
Andrews, IP; Nolan, M; Prager, P; Williams, GD	1
Chase, E; Harris, K; Katpally, U; Reisdorph, N; Siuzdak, G; Smith, TJ; Thomas, JJ	1
Fleischer, R; Laessig, K	1
Abzug, MJ	2
Bryant, PA; Curtis, N; Dargaville, PA; Starr, M; Tingay, D	1
Collett, MS; Demenczuk, TM; Herbertz, T; Ledford, RM; Patel, NR; Pevear, DC; Watanyar, A	1
Bator, CM; Chakravarty, S; Demenczuk, TM; Ledford, RM; Pevear, DC; Rossmann, MG; Simpson, AA; Skochko, GA; Watanyar, A; Zhang, Y	1
Webster, AD	1
Birch-Hirschfeld, E; Hammerschmidt, E; Makarov, VA; Riabova, OB; Schmidtke, M; Schüler, S; Wutzler, P; Zell, R	1
Collett, MS; Ledford, RM; Pevear, DC	1
Barone, LR; Collett, MS; Demenczuk, TM; Hayden, FG; McKinlay, MA; Pevear, DC	1
Bertino, JS; Gartung, AM; Liu, S; Ma, JD; Nafziger, AN; Rhodes, G	1
Bertino, JS; Liu, S; Ma, JD; Nafziger, AN; Rhodes, G	1
Byington, CL; Fujinami, RS; Libbey, JE; Rentz, AC; Whitby, FG	1
Accortt, NA; Desmond, RA; Soong, SJ; Talley, L; Villano, SA; Whitley, RJ	1
Berg, AK; Frisk, G; Korsgren, O; Olsson, A	1
Makarov, VA; Riabova, OB; Schmidtke, M; Wutzler, P; Zieger, R	1
Berggren, PO; Blixt, M; Holmberg, R; Juntti-Berggren, L; Klitz, W; Niklasson, B	1
Baek, SH; Choi, HJ; Kwon, DH; Lim, CH; Song, JH	1
Cardosa, MJ; Lewthwaite, P; Ooi, MH; Solomon, T; Wong, SC	1
Harvala, H; Pajkrt, D; Wildenbeest, JG; Wolthers, KC	1
Greenwood, V	1
Boelens, JJ; Douma, JW; Rademaker, C; Sanders, EA; van de Ven, AA; van Loon, AM; van Montfrans, JM; Wensing, AM	1
Cao, Q; Deng, Y; Ding, C; Feng, D; Gu, B; Hu, W; Wang, J; Xie, F; Yao, K; Zhang, C; Zhang, G; Zhou, F	1
Benschop, KS; Koen, G; Kuijpers, TW; van den Broek, PJ; Vossen, AC; Wierenga, PC; Wildenbeest, JG; Wolthers, KC	1
Hussain Basha, S; Prasad, RN	1
Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M	1
Benschop, KSM; Koen, G; Minnaar, RP; Pajkrt, D; van den Broek, PJ; van Hemert, FJ; Vossen, ACTM; Westerhuis, BM; Wildenbeest, JG; Wolthers, KC	1
Fokine, A; Kihara, D; Kuhn, RJ; Liu, Y; Long, F; Meng, G; Rossmann, MG; Sheng, J; Shin, WH	1
Bernard, A; Cabiddu, MG; Lacroix, C; Leyssen, P; Neyts, J; Pompei, R	1
Angius, F; Coluccia, A; Laconi, S; Lacroix, C; Leyssen, P; Neyts, J; Pompei, R; Silvestri, R	1
Galabov, AS; Nikolova, I; Stoyanova, A	1
Baggen, J; Delang, L; Froeyen, M; George, S; Hilgenfeld, R; Leyssen, P; Meijer, A; Neyts, J; Sun, L; Thibaut, HJ; van Kuppeveld, FJ; Vernachio, J; Zhang, L	1
Braun, H; Glen, RC; Kirchmair, J; Makarov, VA; Riabova, OB; Sauerbrei, A; Schmidtke, M; Williamson, MJ	1
Abzug, MJ; Acosta, EP; Cloud, G; Dennehy, P; Jacobs, RF; Jester, P; Kimberlin, D; Krogstad, P; Lawrence, R; Michaels, MG; Palmer, A; Robinson, J; Romero, JR; Sánchez, PJ; Shelton, M; Sood, SK; Storch, GA; Wald, E; Whitley, R; Wilson, G	1
Häkkinen, H; Lahtinen, T; Malola, S; Marjomäki, V; Martikainen, M; Permi, P; Salorinne, K	1
Cheng, XY; Jiang, JD; Kong, LY; Li, YH; Song, DQ; Tang, S; Wang, HQ; Zhang, X	1
Day, CW; Evans, WJ; Nicolaou, KC; Smee, DF; Tarbet, EB	1
Hernández, M	1
Muller, WJ	1
Dimitrov, V; Dobrikov, G; Galabov, AS; Nikolova, I; Philipov, S; Pürstinger, G; Stoyanova, A	1
Groenhof, G; Häkkinen, H; Malola, S; Pohjolainen, E	1
Abdelnabi, R; Delang, L; Froeyen, M; Luyten, W; Ma, Y; Mirabelli, C; Neyts, J	1
Baršić, B; Kutleša, M; Radanović, I; Rkman, D; Zekan, P	1
DeBiasi, RL; Harik, N	1
Lv, W; Wang, Y; Zhang, M; Zhang, Y	1
Blaas, D; Goessweiner-Mohr, N; Kirchmair, J; Makarov, VA; Marlovits, TC; Mathai, N; Pasin, M; Real-Hohn, A; Richter, M; Schmidtke, M; Verdaguer, N; Wald, J; Walther, C; Zanella, I	1
Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB	1
Egorova, A; Ekins, S; Jahn, B; Kazakova, E; Makarov, V; Schmidtke, M	1
Egorova, A; Ekins, S; Galochkina, A; Makarov, V; Volobueva, A; Zarubaev, V	1
Berggren, PO; Juntti-Berggren, L; Klitz, W; Lindquist, L; Niklasson, B	1
Galabov, AS; Stoyanova, A	1
Füzik, T; Kalynych, S; Moravcová, J; Plevka, P	1

Reviews

19 review(s) available for pleconaril and oxazoles

Article	Year
Antiviral therapy for enteroviral infections. The Pediatric infectious disease journal, 1999, Volume: 18, Issue:7 Topics: Adult; Antiviral Agents; Enterovirus Infections; Humans; Immunization, Passive; Infant, Newborn; Oxadiazoles; Oxazoles; Randomized Controlled Trials as Topic	1999
Update on influenza and rhinovirus infections. Advances in experimental medicine and biology, 1999, Volume: 458 Topics: Acetamides; Amines; Antiviral Agents; Common Cold; Guanidines; Humans; Influenza, Human; Intercellular Adhesion Molecule-1; Neuraminidase; Oseltamivir; Oxadiazoles; Oxazoles; Picornaviridae Infections; Pyrans; Recombinant Proteins; Rhinovirus; Sialic Acids; Zanamivir	1999
Pleconaril. A broad spectrum antipicornaviral agent. Advances in experimental medicine and biology, 1999, Volume: 458 Topics: Antiviral Agents; Enterovirus; Humans; Meningitis, Viral; Oxadiazoles; Oxazoles; Picornaviridae Infections	1999
Enterovirus infections: diagnosis and treatment. The Pediatric infectious disease journal, 1999, Volume: 18, Issue:12 Topics: Antiviral Agents; Child; Cost of Illness; Enterovirus; Enterovirus Infections; Humans; Meningitis, Viral; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Serologic Tests	1999
[On new antiviral drugs, new viruses and old known bacteria]. Schweizerische medizinische Wochenschrift, 1999, Dec-28, Volume: 129, Issue:51-52 Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Bacterial Infections; Enterovirus; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Virus Diseases; Viruses	1999
[Pleconaril, a new aniviral drug with activity against picornavirus]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:3 Topics: Animals; Antiviral Agents; Drug Resistance; Humans; Oxadiazoles; Oxazoles; Picornaviridae; Picornaviridae Infections	2000
The treatment of rhinovirus infections: progress and potential. Antiviral research, 2001, Volume: 49, Issue:1 Topics: 3C Viral Proteases; Antiviral Agents; Clinical Trials as Topic; Combined Modality Therapy; Common Cold; Cysteine Endopeptidases; Dietary Supplements; Drug Therapy, Combination; Echinacea; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Intercellular Adhesion Molecule-1; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Phytotherapy; Picornaviridae Infections; Plant Extracts; Plants, Medicinal; Pyrrolidinones; Receptors, Virus; Rhinovirus; Valine; Viral Proteins; Zinc	2001
Enterovirus infections: diagnosis and treatment. Current opinion in pediatrics, 2001, Volume: 13, Issue:1 Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Enterovirus Infections; Female; Humans; Infant; Infant, Newborn; Meningitis, Viral; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Sepsis	2001
What's new with enteroviral infections? Current opinion in pediatrics, 2001, Volume: 13, Issue:1 Topics: Antiviral Agents; Cost-Benefit Analysis; Disease Outbreaks; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Romania; Scotland	2001
Pleconaril Sanofi Synthélabo/ViroPharma. Current opinion in investigational drugs (London, England : 2000), 2000, Volume: 1, Issue:3 Topics: Antiviral Agents; Clinical Trials as Topic; Contraindications; Drugs, Investigational; Humans; Oxadiazoles; Oxazoles; Picornaviridae; Picornaviridae Infections; Structure-Activity Relationship	2000
Enterovirus infections: diagnosis and treatment. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Adult; Antiviral Agents; Child; Clinical Trials as Topic; Enterovirus Infections; Humans; Meningitis, Viral; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Virus Replication	2002
Pleconaril, a novel antipicornaviral agent. Pharmacotherapy, 2003, Volume: 23, Issue:3 Topics: Adolescent; Adult; Aged; Antiviral Agents; Area Under Curve; Biological Availability; Half-Life; Humans; Middle Aged; Oxadiazoles; Oxazoles; Picornaviridae Infections; Randomized Controlled Trials as Topic	2003
Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatric drugs, 2004, Volume: 6, Issue:1 Topics: Adult; Antiviral Agents; Child; Enterovirus Infections; Humans; Infant, Newborn; Oxadiazoles; Oxazoles; Randomized Controlled Trials as Topic; Viral Vaccines	2004
Pleconaril--an advance in the treatment of enteroviral infection in immuno-compromised patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2005, Volume: 32, Issue:1 Topics: Antiviral Agents; Enterovirus Infections; Humans; Immunocompromised Host; Oxadiazoles; Oxazoles; Poliovirus	2005
Clinical features, diagnosis, and management of enterovirus 71. The Lancet. Neurology, 2010, Volume: 9, Issue:11 Topics: Disease Management; Enterovirus A, Human; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles	2010
The need for treatment against human parechoviruses: how, why and when? Expert review of anti-infective therapy, 2010, Volume: 8, Issue:12 Topics: Animals; Antiviral Agents; Central Nervous System Infections; Disease Models, Animal; Humans; Infant, Newborn; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Sepsis	2010
The enteroviruses: problems in need of treatments. The Journal of infection, 2014, Volume: 68 Suppl 1 Topics: Antiviral Agents; Drug Discovery; Enterovirus Infections; Global Health; Humans; Oxadiazoles; Oxazoles	2014
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatric research, 2017, Volume: 81, Issue:1-2 Topics: Acyclovir; Antiviral Agents; Brain; Cognition; Cognition Disorders; Encephalitis, Herpes Simplex; Enterovirus Infections; Female; Ganciclovir; HIV Infections; Humans; Infant, Newborn; Nervous System Diseases; Oxadiazoles; Oxazoles; Pregnancy; Valganciclovir; Virus Diseases	2017
Neonatal nonpolio enterovirus and parechovirus infections. Seminars in perinatology, 2018, Volume: 42, Issue:3 Topics: Antiviral Agents; Cross Infection; Enterovirus; Enterovirus Infections; Female; Fomites; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Oxadiazoles; Oxazoles; Parechovirus; Phenyl Ethers; Picornaviridae Infections; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious	2018

Trials

15 trial(s) available for pleconaril and oxazoles

Article	Year
Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Cross-Over Studies; Food; Humans; Oxadiazoles; Oxazoles; Picornaviridae; Solutions	1998
Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric Pharmacology Research Unit Network. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3 Topics: Administration, Oral; Aging; Antiviral Agents; Area Under Curve; Child; Child, Preschool; Female; Humans; Male; Oxadiazoles; Oxazoles; Pharmaceutical Solutions	1999
Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults. Journal of clinical pharmacology, 1999, Volume: 39, Issue:6 Topics: Administration, Oral; Adult; Antiviral Agents; Area Under Curve; Capsules; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Humans; Male; Middle Aged; Oxadiazoles; Oxazoles; Single-Blind Method	1999
Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. The Journal of infectious diseases, 2000, Volume: 181, Issue:1 Topics: Adolescent; Adult; Antibodies, Viral; Antiviral Agents; Coxsackievirus Infections; Enterovirus; Female; Humans; Male; Middle Aged; Mucus; Nose; Oxadiazoles; Oxazoles; Respiratory Tract Infections; Virus Shedding	2000
Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network. The Pediatric infectious disease journal, 2000, Volume: 19, Issue:9 Topics: Administration, Oral; Age Factors; Antiviral Agents; Area Under Curve; Biological Availability; Enterovirus Infections; Female; Humans; Infant, Newborn; Male; Oxadiazoles; Oxazoles	2000
Treatment of potentially life-threatening enterovirus infections with pleconaril. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jan-15, Volume: 32, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Enterovirus; Enterovirus Infections; Follow-Up Studies; Humans; Infant, Newborn; Meningoencephalitis; Middle Aged; Oxadiazoles; Oxazoles; Treatment Outcome	2001
Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Antiviral therapy, 2002, Volume: 7, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxadiazoles; Oxazoles; Picornaviridae Infections; Respiratory Tract Infections; Virus Shedding	2002
Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. European journal of pediatrics, 2002, Volume: 161, Issue:9 Topics: Antiviral Agents; Coxsackievirus Infections; Diseases in Twins; Enterovirus B, Human; Female; Humans; Infant, Newborn; Infant, Premature; Oxadiazoles; Oxazoles	2002
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. The Pediatric infectious disease journal, 2003, Volume: 22, Issue:4 Topics: Administration, Oral; Biological Availability; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enterovirus Infections; Female; Follow-Up Studies; Humans; Infant; Male; Meningitis, Viral; Oxadiazoles; Oxazoles; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome	2003
Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jun-15, Volume: 36, Issue:12 Topics: Administration, Oral; Adult; Antiviral Agents; Common Cold; Diarrhea; Double-Blind Method; Female; Humans; Male; Nausea; Oxadiazoles; Oxazoles; Picornaviridae; Picornaviridae Infections; Prospective Studies; Treatment Outcome	2003
Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11 Topics: Antiviral Agents; Common Cold; Double-Blind Method; Drug Resistance, Bacterial; Humans; Oxadiazoles; Oxazoles; Rhinovirus	2005
The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe. Journal of clinical pharmacology, 2006, Volume: 46, Issue:1 Topics: Administration, Oral; Adult; Antiviral Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Injections, Intravenous; Liver; Male; Midazolam; Oxadiazoles; Oxazoles	2006
Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:7 Topics: Adult; Antiviral Agents; Double-Blind Method; Enterovirus Infections; Female; Headache; Humans; Male; Meningitis, Viral; Multivariate Analysis; Oxadiazoles; Oxazoles; Treatment Outcome	2006
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. Journal of the Pediatric Infectious Diseases Society, 2016, Volume: 5, Issue:1 Topics: Antiviral Agents; Double-Blind Method; Enterovirus; Enterovirus Infections; Female; Humans; Infant; Infant, Newborn; Male; Neonatal Sepsis; Oropharynx; Oxadiazoles; Oxazoles; Rectum	2016
[A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2016, Volume: 33, Issue:3 Topics: Antiviral Agents; Double-Blind Method; Enterovirus Infections; Female; Humans; Infant, Newborn; Male; Neonatal Sepsis; Oxadiazoles; Oxazoles; Placebo Effect; Reproducibility of Results; Time Factors; Treatment Outcome	2016

Other Studies

58 other study(ies) available for pleconaril and oxazoles

Article	Year
Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. The Journal of infectious diseases, 1999, Volume: 179, Issue:6 Topics: Animals; Antiviral Agents; Binding Sites; Capsid; Capsid Proteins; Drug Resistance, Microbial; Enterovirus B, Human; Genetic Variation; Male; Mice; Mice, Inbred BALB C; Oxadiazoles; Oxazoles; RNA, Viral; Sequence Analysis, RNA	1999
Activity of pleconaril against enteroviruses. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:9 Topics: Animals; Animals, Newborn; Animals, Suckling; Antiviral Agents; Cells, Cultured; Coxsackievirus Infections; Enterovirus; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Oxadiazoles; Oxazoles; Serotyping; Virus Replication	1999
Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment. European journal of pediatrics, 1999, Volume: 158, Issue:12 Topics: Adult; Agammaglobulinemia; Antiviral Agents; Enterovirus; Genetic Linkage; Humans; Male; Meningoencephalitis; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; X Chromosome	1999
[New antivirals for respiratory tract viruses]. Presse medicale (Paris, France : 1983), 1999, Nov-27, Volume: 28 Suppl 3 Topics: Antiviral Agents; Drug Approval; France; Guanidines; Humans; Influenza, Human; Neuraminidase; Oxadiazoles; Oxazoles; Picornaviridae Infections; Pyrans; Respiratory Tract Infections; Sialic Acids; Zanamivir	1999
Diagnosis and prospective treatment of enteroviral infections in children. Clinical pediatrics, 2000, Volume: 39, Issue:4 Topics: Antiviral Agents; Child; Diagnosis, Differential; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral	2000
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral research, 2000, Volume: 47, Issue:3 Topics: Antiviral Agents; Cell Survival; Cells, Cultured; Common Cold; Humans; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Reverse Transcriptase Polymerase Chain Reaction; Rhinovirus; Spectrophotometry; Valine	2000
Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Volume: 32, Issue:1 Topics: Antiviral Agents; Enterovirus Infections; Feces; Female; Humans; Infant; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; RNA, Viral; Severe Combined Immunodeficiency	2001
Pleconaril: a novel antipicornaviral drug. Expert opinion on investigational drugs, 2001, Volume: 10, Issue:2 Topics: Antiviral Agents; Clinical Trials as Topic; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles	2001
Treatment of ALS with pleconaril. Neurology, 2001, Mar-13, Volume: 56, Issue:5 Topics: Aged; Amyotrophic Lateral Sclerosis; Humans; Male; Oxadiazoles; Oxazoles	2001
Severe neonatal enteroviral hepatitis treated with pleconaril. The Pediatric infectious disease journal, 2001, Volume: 20, Issue:4 Topics: Antiviral Agents; Echovirus Infections; Enterovirus B, Human; Hepatitis, Viral, Human; Humans; Infant, Newborn; Liver Failure; Oxadiazoles; Oxazoles	2001
Acute flaccid paralysis syndrome associated with echovirus 19, managed with pleconaril and intravenous immunoglobulin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Sep-01, Volume: 33, Issue:5 Topics: Adult; Antiviral Agents; Echovirus Infections; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Kidney Transplantation; Lung Transplantation; Oxadiazoles; Oxazoles; Paraplegia	2001
Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. Journal of medicinal chemistry, 2002, Apr-11, Volume: 45, Issue:8 Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Enterovirus; Humans; Imidazoles; Neutralization Tests; Oxadiazoles; Oxazoles; Pyridines; Structure-Activity Relationship; Viral Plaque Assay	2002
FDA panel rejects common cold treatment. The Lancet. Infectious diseases, 2002, Volume: 2, Issue:5 Topics: Antiviral Agents; Common Cold; Drug Approval; Female; Humans; Oxadiazoles; Oxazoles; United States; United States Food and Drug Administration	2002
Cold comfort. The Lancet. Infectious diseases, 2002, Volume: 2, Issue:7 Topics: Antiviral Agents; Common Cold; Drug Approval; Humans; Oxadiazoles; Oxazoles; United States; United States Food and Drug Administration	2002
SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis. The Journal of infection, 2003, Volume: 46, Issue:2 Topics: Adolescent; Adult; Antiviral Agents; Common Variable Immunodeficiency; Enterovirus; Enterovirus Infections; Female; HIV Infections; Humans; Immunocompromised Host; Male; Meningoencephalitis; Oxadiazoles; Oxazoles; Tomography, Emission-Computed, Single-Photon	2003
Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology, 2003, May-27, Volume: 60, Issue:10 Topics: Acute Disease; Antiviral Agents; Child, Preschool; Combined Modality Therapy; Disease Outbreaks; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Infant; Magnetic Resonance Imaging; Male; New South Wales; Oxadiazoles; Oxazoles; Pulmonary Edema; Survival Analysis; Survivors	2003
Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2003, Volume: 4, Issue:3 Topics: Antiviral Agents; Child, Preschool; Echocardiography; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Female; Follow-Up Studies; Humans; Infant; Intensive Care Units, Pediatric; Magnetic Resonance Imaging; Male; Oxadiazoles; Oxazoles; Pulmonary Edema; Respiration, Artificial; Time Factors	2003
Human rhinovirus capsid dynamics is controlled by canyon flexibility. Virology, 2003, Sep-15, Volume: 314, Issue:1 Topics: Antibodies, Viral; Antigen-Antibody Reactions; Binding Sites; Capsid; HeLa Cells; Humans; Immunoglobulin Fab Fragments; Isoxazoles; Microscopy, Electron; Models, Molecular; Mutation; Oxadiazoles; Oxazoles; Rhinovirus; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Virus Assembly	2003
Safety and efficacy evaluation of pleconaril for treatment of the common cold. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-15, Volume: 37, Issue:12 Topics: Adult; Antiviral Agents; Common Cold; Controlled Clinical Trials as Topic; Drug Resistance, Viral; Evaluation Studies as Topic; Humans; Oxadiazoles; Oxazoles; Picornaviridae Infections	2003
Neonatal coxsackie B virus infection-a treatable disease? European journal of pediatrics, 2004, Volume: 163, Issue:4-5 Topics: Antiviral Agents; Cardiomyopathies; Coxsackievirus Infections; Disseminated Intravascular Coagulation; Enterovirus B, Human; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Meningoencephalitis; Oxadiazoles; Oxazoles; Perinatal Care; Polymerase Chain Reaction; Thrombocytopenia	2004
VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. Journal of virology, 2004, Volume: 78, Issue:7 Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Drug Resistance, Viral; HeLa Cells; Humans; Models, Molecular; Molecular Sequence Data; Neutralization Tests; Oxadiazoles; Oxazoles; Phylogeny; Rhinovirus; Viral Proteins	2004
Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds. Journal of virology, 2004, Volume: 78, Issue:20 Topics: Antiviral Agents; Binding Sites; Crystallization; HeLa Cells; Humans; Models, Molecular; Oxadiazoles; Oxazoles; Rhinovirus; Virus Assembly; Virus Replication; X-Ray Diffraction	2004
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4 Topics: Amino Acid Substitution; Animals; Antiviral Agents; Capsid; Capsid Proteins; Cell Line; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance, Viral; Enterovirus B, Human; Enterovirus Infections; Humans; Hydrophobic and Hydrophilic Interactions; Oxadiazoles; Oxazoles; Polymorphism, Genetic	2005
Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril. Antiviral research, 2005, Volume: 68, Issue:3 Topics: Antiviral Agents; Capsid Proteins; Drug Resistance, Viral; Humans; Oxadiazoles; Oxazoles; Rhinovirus	2005
Duration of pleconaril effect on cytochrome P450 3A activity in healthy adults using the oral biomarker midazolam. Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:5 Topics: Adult; Antiviral Agents; Area Under Curve; Cytochrome P-450 CYP3A; Enzyme Induction; Female; Half-Life; Humans; Hypnotics and Sedatives; Intestines; Liver; Male; Midazolam; Middle Aged; Oxadiazoles; Oxazoles	2006
Investigation of treatment failure in neonatal echovirus 7 infection. The Pediatric infectious disease journal, 2006, Volume: 25, Issue:3 Topics: Antiviral Agents; Enterovirus B, Human; Enterovirus Infections; Fatal Outcome; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Molecular Sequence Data; Oxadiazoles; Oxazoles; Sequence Analysis, DNA; Treatment Failure	2006
Antiviral treatment of Coxsackie B virus infection in human pancreatic islets. Antiviral research, 2007, Volume: 74, Issue:1 Topics: Antiviral Agents; Cells, Cultured; Coxsackievirus Infections; Cytopathogenic Effect, Viral; Diabetes Mellitus, Type 1; Enterovirus B, Human; Humans; Insulin; Islets of Langerhans; Oxadiazoles; Oxazoles	2007
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. Antiviral research, 2009, Volume: 81, Issue:1 Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Enterovirus B, Human; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Mutation; Oxadiazoles; Oxazoles	2009
Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats. Microbiology and immunology, 2009, Volume: 53, Issue:10 Topics: Animals; Antibodies, Viral; Antiviral Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Immunologic Factors; Mice; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Rats; Rats, Inbred BB; Ribavirin	2009
Anti-human rhinovirus activity of raoulic acid from Raoulia australis. Journal of medicinal food, 2010, Volume: 13, Issue:2 Topics: Antiviral Agents; Asteraceae; Common Cold; Humans; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phytotherapy; Picornaviridae Infections; Plant Extracts; Rhinovirus; Ribavirin; Terpenes; Virus Internalization	2010
Curing the common cold. Scientific American, 2011, Volume: 304, Issue:1 Topics: Antiviral Agents; Common Cold; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oxadiazoles; Oxazoles; Rhinovirus; Viral Structural Proteins; Viral Vaccines	2011
Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia. Antiviral therapy, 2011, Volume: 16, Issue:4 Topics: Adolescent; Agammaglobulinemia; Antiviral Agents; Caliciviridae Infections; Chronic Disease; Drug Resistance, Viral; Feces; Humans; Immunocompromised Host; Male; Norovirus; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Protein-Losing Enteropathies	2011
In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Archives of virology, 2012, Volume: 157, Issue:4 Topics: Animals; Animals, Newborn; Antiviral Agents; Cell Line, Tumor; Cell Survival; Child, Preschool; Disease Models, Animal; Enterovirus A, Human; Enterovirus Infections; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Ribavirin; Survival Analysis	2012
Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility. Antiviral therapy, 2012, Volume: 17, Issue:3 Topics: Antiviral Agents; Cerebrospinal Fluid; Child; Chronic Disease; Drug Resistance, Viral; Enterovirus; Enterovirus Infections; Female; Humans; Immunoglobulins, Intravenous; Male; Meningoencephalitis; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Treatment Outcome	2012
In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. BMC research notes, 2012, Feb-17, Volume: 5 Topics: Amino Acids; Antiviral Agents; Binding Sites; Biocatalysis; Catalytic Domain; Drug Evaluation, Preclinical; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Hydrogen Bonding; Influenza A Virus, H1N1 Subtype; Influenza, Human; Models, Molecular; Molecular Structure; Neuraminidase; Oseltamivir; Oxadiazoles; Oxazoles; Protein Binding; Protein Structure, Tertiary	2012
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication	2014
Genetic and antigenic structural characterization for resistance of echovirus 11 to pleconaril in an immunocompromised patient. The Journal of general virology, 2015, Volume: 96, Issue:Pt 3 Topics: Antigens, Viral; Antiviral Agents; Drug Resistance, Viral; Echovirus Infections; Enterovirus B, Human; Gene Expression Regulation, Viral; Humans; Immunoglobulins, Intravenous; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxadiazoles; Oxazoles	2015
Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science (New York, N.Y.), 2015, Jan-02, Volume: 347, Issue:6217 Topics: Antiviral Agents; Capsid; Child; Crystallography, X-Ray; Enterovirus D, Human; Enterovirus Infections; Humans; Hydrophobic and Hydrophilic Interactions; Oxadiazoles; Oxazoles; Respiratory Tract Diseases; United States; Viral Proteins	2015
Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds. Antiviral chemistry & chemotherapy, 2015, Volume: 24, Issue:2 Topics: Antiviral Agents; Dose-Response Relationship, Drug; Enterovirus; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Piperidines; Pyridazines; Structure-Activity Relationship	2015
In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. Virology journal, 2015, Jul-14, Volume: 12 Topics: Antiviral Agents; Capsid Proteins; Humans; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Piperidines; Protein Binding; Pyridazines; Rhinovirus	2015
Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice. Antiviral research, 2015, Volume: 121 Topics: Animals; Antiviral Agents; Apomorphine; Brain; Central Nervous System Infections; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Survival Analysis; Treatment Outcome	2015
Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Antiviral Agents; Drug Resistance, Viral; Enterovirus D, Human; Enterovirus Infections; Humans; Microbial Sensitivity Tests; Models, Molecular; Oxadiazoles; Oxazoles; Receptors, Drug; Respiratory Tract Infections; Viral Proteins; Virus Replication	2015
Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket. Antiviral research, 2015, Volume: 123 Topics: Amino Acid Substitution; Antiviral Agents; Binding Sites; Capsid Proteins; DNA Mutational Analysis; Drug Resistance, Viral; Enterovirus B, Human; HeLa Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Mutation, Missense; Oxadiazoles; Oxazoles; Protein Binding; Protein Conformation; Virus Replication	2015
Hydrophobic pocket targeting probes for enteroviruses. Nanoscale, 2015, Nov-07, Volume: 7, Issue:41 Topics: Cell Line, Tumor; Coxsackievirus Infections; Enterovirus B, Human; Fluorescent Dyes; Gold; Humans; Hydrophobic and Hydrophilic Interactions; Oxadiazoles; Oxazoles	2015
SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors. Future medicinal chemistry, 2016, Volume: 8, Issue:5 Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Coxsackievirus Infections; Drug Discovery; Drug Resistance, Viral; Enterovirus; Humans; Isoquinolines; Male; Mice; Oxadiazoles; Oxazoles; RNA, Viral; Serine Endopeptidases; Structure-Activity Relationship; Sulfonamides; Vero Cells; Viral Proteins	2016
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds. Antiviral research, 2016, Volume: 131 Topics: A549 Cells; Antimetabolites; Antiviral Agents; Benzimidazoles; Enterovirus A, Human; Enterovirus D, Human; Guanine; HeLa Cells; Humans; Oxadiazoles; Oxazoles; Oximes; Picornaviridae; Piperazines; Piperidines; Pyridazines; Rhabdomyosarcoma; Rhinovirus; Ribavirin; Sulfonamides	2016
Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice. Antiviral chemistry & chemotherapy, 2015, Volume: 24, Issue:5-6 Topics: Animals; Antiviral Agents; Apomorphine; Cells, Cultured; Coxsackievirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Oxadiazoles; Oxazoles; Virus Replication	2015
Exploring Strategies for Labeling Viruses with Gold Nanoclusters through Non-equilibrium Molecular Dynamics Simulations. Bioconjugate chemistry, 2017, 09-20, Volume: 28, Issue:9 Topics: Antiviral Agents; Binding Sites; Capsid; Enterovirus; Gold; Hydrophobic and Hydrophilic Interactions; Ligands; Metal Nanoparticles; Molecular Dynamics Simulation; Oxadiazoles; Oxazoles; Palmitic Acid; Thermodynamics	2017
New class of early-stage enterovirus inhibitors with a novel mechanism of action. Antiviral research, 2017, Volume: 147 Topics: Antiviral Agents; Capsid; Capsid Proteins; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Viral; Drug Synergism; Enterovirus B, Human; Enterovirus Infections; Genotype; Humans; Molecular Conformation; Molecular Docking Simulation; Oxadiazoles; Oxazoles; para-Aminobenzoates; Protein Binding; RNA, Viral; Structure-Activity Relationship; Virus Replication	2017
Chronic meningoencephalitis caused by Echo virus 6 in a patient with common variable immunodeficiency : Successful treatment with pleconaril. Wiener klinische Wochenschrift, 2018, Volume: 130, Issue:1-2 Topics: Adult; Common Variable Immunodeficiency; Echovirus 6, Human; Echovirus Infections; Humans; Male; Meningoencephalitis; Oxadiazoles; Oxazoles; Treatment Outcome	2018
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses. Scientific reports, 2019, 04-15, Volume: 9, Issue:1 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Enterovirus; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Luminescent Measurements; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Valine; Vero Cells	2019
Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site. Proceedings of the National Academy of Sciences of the United States of America, 2019, 09-17, Volume: 116, Issue:38 Topics: Antiviral Agents; Binding Sites; Capsid; Cryoelectron Microscopy; Drug Resistance, Viral; HeLa Cells; Humans; Models, Molecular; Molecular Structure; Oxadiazoles; Oxazoles; Picornaviridae Infections; Protein Binding; Protein Conformation; Rhinovirus; Structure-Activity Relationship; Viral Proteins	2019
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses. Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:11 Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides	2020
Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. European journal of medicinal chemistry, 2020, Feb-15, Volume: 188 Topics: Animals; Antiviral Agents; Cell Survival; Dose-Response Relationship, Drug; Enterovirus; HeLa Cells; Humans; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Oxazoles; Structure-Activity Relationship	2020
The Evolution of Pleconaril: Modified Molecules (Basel, Switzerland), 2020, Mar-16, Volume: 25, Issue:6 Topics: Animals; Antiviral Agents; Cell Death; Chlorocebus aethiops; Dogs; Enterovirus B, Human; Madin Darby Canine Kidney Cells; Oxadiazoles; Oxazoles; Piperazines; Vero Cells	2020
Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials. Viral immunology, 2020, Volume: 33, Issue:9 Topics: Adult; Alkynes; Animals; Antiviral Agents; Benzoxazines; Cyclopropanes; Diabetes Mellitus, Type 1; Humans; Male; Oxadiazoles; Oxazoles; Proof of Concept Study; Rats; Ribavirin	2020
Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3. Pathogens and disease, 2020, 11-23, Volume: 78, Issue:9 Topics: Animals; Antiviral Agents; Apomorphine; Cell Line; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Nitriles; Oxadiazoles; Oxazoles; Virus Replication	2020
Structure of Human Enterovirus 70 and Its Inhibition by Capsid-Binding Compounds. Journal of virology, 2022, 09-14, Volume: 96, Issue:17 Topics: Antiviral Agents; Capsid; Capsid Proteins; Conjunctivitis, Acute Hemorrhagic; Cryoelectron Microscopy; Enterovirus D, Human; Humans; Oxadiazoles; Oxazoles; Virion	2022